Unraveling the ischemic brain transcriptome in a permanent middle cerebral artery occlusion mouse model by DNA microarray analysis

DMM Disease Models and Mechanisms

Volumn 5, Issue 2, 2012, Pages 270-283

  Hori, Motohide ^a,b   Nakamachi, Tomoya ^b   Rakwal, Randeep ^b,c   Shibato, Junko ^b   Nakamura, Keisuke ^b   Wada, Yoshihiro ^b   Tsuchikawa, Daisuke ^b   Yoshikawa, Akira ^b   Tamaki, Keiji ^a   Shioda, Seiji ^b  

^a KYOTO UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; MATRIX METALLOPROTEINASE; PROTEIN S 100; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; GENE EXPRESSION; HEMISPHERE; MICROARRAY ANALYSIS; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTINS; ANIMALS; BRAIN ISCHEMIA; CHEMOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; S100 PROTEINS; TIME FACTORS; TRANSCRIPTOME;

MUS;

EID: 84858020909     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.008276     Document Type: Article

References (93)

1. Albaiceta, G. M., Gutierrez-Fernández, A., García-Prieto, E., Puente, X. S., Parra, D., Astudillo, A., Campestre, C., Cabrera, S., Gonzalez-Lopez, A., Fueyo, A. et al. (2010). Absence or inhibition of matrix metalloproteinase-8 decreases ventilatorinduced lung injury. Am. J. Respir. Cell Mol. Biol. 43, 555-563.
2. Altman, N. (2005). Replication, variation and normalisation in microarray experiments. Appl. Bioinformatics 4, 33-44.
3. Brait, V. H., Rivera, J., Broughton, B. R., Lee, S., Drummond, G. R. and Sobey, C. G. (2011). Chemokine-related gene expression in the brain following ischemic stroke: no role for CXCR2 in outcome. Brain Res. 1372, 169-179.
4. Büttner, F., Cordes, C., Gerlach, F., Heimann, A., Alessandri, B., Luxemburger, U., Türeci, O., Hankeln, T., Kempski, O. and Burmester, T. (2008). Genomic response of the rat brain to global ischemia and reperfusion. Brain Res. 1252, 1-14.
5. Cauwe, B., Van den Steen, P. E. and Opdenakker, G. (2007). The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit. Rev. Biochem. Mol. Biol. 42, 113-185.
6. Chauveau, F., Cho, T. H., Berthezène, Y., Nighoghossian, N. and Wiart, M. (2010). Imaging inflammation in stroke using magnetic resonance imaging. Int. J. Clin. Pharmacol. Ther. 48, 718-728.
7. Choi, D. H., Kim, E. M., Son, H. J., Joh, T. H., Kim, Y. S., Kim, D., Flint Beal, M. and Hwang, O. (2008). A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells. J. Neurochem. 106, 405-415.
8. Clark, W. M., Rinker, L. G., Lessoy, N. S., Hazel, K., Hill, J. K., Stenzel-Poore, M. and Eckenstein, F. (2000). Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke 31, 1715-1720.
9. Cox, J. H., Starr, A. E., Kappelhoff, R., Yan, R., Roberts, C. R. and Overall, C. M. (2010). Matrix metalloproteinase 8 deficiency in mice exacerbates inflammatory arthritis through delayed neutrophil apoptosis and reduced caspase 11 expression. Arthritis Rheum. 62, 3645-3655.
10. Crocker, S. J., Pagenstecher, A. and Campbell, I. L. (2004). The TIMPs tango with MMPs and more in the central nervous system. J. Neurosci. Res. 75, 1-11.
11. Cucchiara, B. and Kasner, S. E. (2011). In the clinic. Transient ischemic attack. Ann. Intern. Med. 154, 1-16.
12. D'Acquisto, F., May, M. J. and Gosh, S. (2002). Inhibition of nuclear factor kappa B (NF-B): an emerging theme in anti-inflammatory therapies. Mol. Interv. 2, 22-35.
13. Debets, R., Timans, J. C., Homey, B., Zurawski, S., Sana, T. R., Lo, S., Wagner, J., Edwards, G., Clifford, T., Menon, S., Bazan, J. F. and Kastelein, R. A. (2001). Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2. J. Immunol. 167, 1440-1446.
14. Dejonckheere, E., Vantenbraoucke, R. E. and Libert, C. (2011). Matrix metalloproteinase8 has a central role in inflammatory disorders and cancer progression. Cytokine Growth Factor Rev. 22, 73-81.
15. DeRisi, J. L. Iyer, V. R. and Brown, P. O. (1997). Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278, 680-686.
16. Di Pietro, V., Amin, D., Pernagallo, S., Lazzarino, G., Tavazzi, B., Vagnozzi R., Pringle, A. and Belli, A. (2010). Transcriptomics of traumatic brain injury: gene expression and molecular pathways of different grades of insult in a rat organotypic hippocampal culture model. J. Neurotrauma 27, 349-359.
17. Dogrukol-Ak, D., Kumar, V. B., Ryerse, J. S., Farr, S. A., Verma, S., Nonaka, N., Nakamachi, T., Ohtaki, H., Niehoff, M. L., Edwards, J. C. et al. (2009). Isolation of peptide transport system-6 from brain endothelial cells: therapeutic effects with antisense inhibition in Alzheimer and stroke models. J. Cereb. Blood Flow Metab. 29, 411-422.
18. Do, M. S., Jeong, H. S., Choi, B. H., Hunter, L., Langley, S., Pazmany, L. and Trayhurn, P. (2006). Inflammatory gene expression patterns revealed by DNA microarray analysis in TNF-alpha-treated SGBS human adipocytes. Yonsei Med. J. 47, 729-736.
19. Fisher. M. (2011). New approaches to neuroprotective drug development. Stroke 42, S24-S27.
20. Gerard, C. and Rollins, B. J. (2001). Chemokines and disease. Nat. Immunol. 2, 108-115.
21. Grond-Ginsbach, C., Horstmann, S., Hummel, M., Wiest, T., Honold, C., Pfleger, K., Hergenhahn, M., Hollstein, M., Weninger, A., Knyazev, Y. et al. (2009). Increased expression of cell-cell signaling genes by stimulated mononuclear leukocytes in patients with previous atherothrombotic stroke. A whole genome expression profile study. Eur. Neurol. 62, 30-39.
22. Gupta, Y. K., Briyal, S. and Gulati, A. (2010). Therapeutic potential of herbal drugs in cerebral ischemia. Indian J. Physiol. Pharmacol. 54, 99-122.
23. Gusev, E. I. and Skvortsova, V. I. (2003). Brain Ischemia. New York: Kluwer Academic/Plenum Publishers.
24. Haramati, O., Mane, R., Molczadzki, G., Perez-Polo, J. R., Chalifa-Caspi, V. and Golan, H. M. (2009). Magnesium sulfate treatment alters fetal cerebellar gene expression responses to hypoxia. Int. J. Dev. Neurosci. 28, 207-216.
25. Harari, O. A. and Liao, J. K. (2010). NF- B and innate immunity in ischemic stroke. Ann. NY Acad. Sci. 1207, 32-40.
26. 2+)-binding protein family. Biometals 11, 383-397.
27. Henninger, N., Kumar, R. and Fisher, M. (2010). Acute ischemic stroke therapy. Expert Rev. Cardiovasc. Ther. 8, 1389-1398.
28. Hirano, M., Rakwal, R., Kouyama, N., Katayama, Y., Hayashi, M., Shibato, J., Ogawa, Y., Yoshida, Y., Iwahashi, H. and Masuo, Y. (2007). Gel-based proteomics of unilateral irradiated striatum after gamma knife surgery. J. Proteome Res. 6, 2656-2668.
29. Hirano, M., Rakwal, R., Shibato, J., Sawa, H., Nagashima, K., Ogawa, Y., Yoshida, Y., Iwahashi, H., Niki, E. and Masuo, Y. (2008). Proteomics- and transcriptomics-based screening of differentially expressed proteins and genes in brain of Wig rat: a model for attention deficit hyperactivity disorder (ADHD) research. J. Proteome Res. 7, 2471-2489.
30. Hirano, M., Shibato, J., Rakwal, R., Kouyama, N., Katayama, Y., Hayashi, M. and Masuo, Y. (2009). Transcriptomic analysis of rat brain tissue following gamma knife surgery: early and distinct bilateral effects in the un-irradiated striatum. Mol. Cells 27, 263-268.
31. Hoenicka, J., Quiñones-Lombraña, A., España-Serrano, L., Alvira-Botero, X., Kremer, L., Pérez-González, R., Rodríguez-Jiménez, R., Jiménez-Arriero, M. A., Ponce, G. and Palomo, T. (2010). The ANKK1 gene associated with addictions is expressed in astroglial cells and upregulated by apomorphine. Biol. Psychiatry 67, 3-11.
32. Indraswari, F., Wong, P. T., Yap, E., Ng, Y. K. and Dheen, S. T. (2009). Upregulation of Dpysl2 and Spna2 gene expression in the rat brain after ischemic stroke. Neurochem. Int. 55, 235-242.
33. Jin, K., Mao, X. O., Eshoo, M. W., Nagayama, T., Minami, M., Simon, R. P. and Greenberg, D. A. (2001). Microarray analysis of hippocampal gene expression in global cerebral ischemia. Ann. Neurol. 50, 93-103.
34. Juul, S. E., Beyer, R. P., Bammler, T. K., McPherson, R. J., Wilkerson, J. and Farin, F. M. (2009). Microarray analysis of high-dose recombinant erythropoietin treatment of unilateral brain injury in neonatal mouse hippocampus. Pediatr. Res. 65, 485-492.
35. Kim, E. M., Shin, E. J., Choi, J. H., Son, H. J., Park, I. S., Joh, T. H. and Hwang, O. (2010). Matrix metalloproteinase-3 is increased and participates in neuronal apoptotic signaling downstream of caspase-12 during endoplasmic reticulum stress. J. Biol. Chem. 285, 16444-16452.
36. Kim, G. S., Jung, J. E., Niizuma, K. and Chan, P. H. (2009). CK2 is a novel negative regulator of NADPH oxidase and a neuroprotectant in mice after cerebral ischemia. J. Neurosci. 29, 14779-14789.
37. Kishimoto, T. (1989). The biology of interleukin-6. Blood 74, 1-10.
38. Kunst, M. M. and Schaefer, P. W. (2011). Ischemic stroke. Radiol. Clin. North Am. 49, 1-26.
39. Kuula, H., Salo, T., Pirilä, E., Tuomainen, A. M., Jauhiainen, M., Uitto, V. J., Tjäderhane, L., Pussinen, P. J. and Sorsa, T. (2009). Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalis-induced periodontitis. Infect. Immun. 77, 850-859.
40. Laxton, R. C., Hu, Y., Duchene, J., Zhang, F., Zhang, Z., Leung, K. Y., Xiao, Q., Scotland, R. S., Hodgkinson, C. P., Smith, K. et al. (2009). A role of matrix metalloproteinase-8 in atherosclerosis. Circ. Res. 105, 921-929.
41. Lee, H., Park, J. W., Kim, S. P., Lo, E. H. and Lee, S. R. (2009). Doxycycline inhibits matrix metalloproteinase-9 and laminin degradation after transient global cerebral ischemia. Neurobiol. Dis. 34, 189-198.
42. Leiva-Salinas, C., Wintermark, M. and Kidwell C. S. (2011). Neuroimaging of cerebral ischemia and infarction. Neurotherapeutics 8, 19-27.
43. Liebeskind, D. S. (2008). Aortic occlusion for cerebral ischemia: from theory to practice. Curr. Cardiol. Rep. 10, 31-36.
44. Martin-Magniette, M. L., Aubert, J., Cabannes, E. and Daudin, J. J. (2005). Evaluation of the gene-specific dye bias in cDNA microarray experiments. Bioinformatics 21, 1995-2000.
45. Masuo, Y., Hirano, M., Shibato, J., Nam, H. W., Fournier, I., Celine, M., Wisztorski, M., Salzet, M., Soya, H., Agrawal, G. K. et al. (2011a). Brain proteomics: sampling preparation techniques for the analysis of rat brain samples using mass spectrometry. In Sample Preparation In Biological Mass Spectrometry (ed. A. Ivanov and A. Lazarev). New York: Springer.
46. Masuo, Y., Shibato, J. and Rakwal, R. (2011b). ADHD animal model characterization: a transcriptomics and proteomics analysis. In Psychiatric Disorders: Methods and Protocols (ed. F. H. Kobeissy). USA: Humana Press Inc., Springer.
47. Meschia, J. F. (2008). Whole genome approaches in ischemic stroke. Stroke 40, S61-S63.
48. Mizushima, H., Sasaki, K., Shimazu, M., Arai, Y., Matsumoto, K., Shioda, S. and Nakai, Y. (1994). Time-dependent changes of vasoactive substances in rat cerebral ischemia. Brain Res. Bull. 34, 541-545.
49. Molina, C. A. (2011). Reperfusion therapies for acute ischemic stroke: current pharmacological and mechanical approaches. Stroke 42, S16-S19.
50. Nakajima, Y., Shimazawa, M., Mishima, S. and Hara, H. (2009). Neuroprotective effects of Brazilian green propolis and its main constituents against oxygen-glucose deprivation stress, with a gene-expression analysis. Phytother. Res. 23, 1431-1438.
51. Nakamachi, T., Endo, S., Ohtaki, H., Yin, L., Kenji, D., Kudo, Y., Funahashi, H., Matsuda, K. and Shioda, S. (2005). Orexin-1 receptor expression after global ischemia in mice. Regul. Pep. 126, 49-54.
52. Nakamachi, T., Ohtaki, H., Yofu, S., Dohi, K., Watanabe, J., Mori, H., Sato, A., Hashimoto, H., Shintani, N., Baba, A. et al. (2010). Endogenous pituitary adenylate cyclase activating polypeptide is involved in suppression of edema in the ischemic brain. Acta Neurochir. 106 Suppl., 43-46.
53. Nishikawa, T., Lee, I. S., Shiraishi, N., Ishikawa, T., Ohta, Y. and Nishikimi, M. (1997). Identification of S100b protein as copper-binding protein and its suppression of copper-induced cell damage. J. Biol. Chem. 272, 23037-23041.
54. Ogawa, T., Rakwal, R., Shibato, J., Sawa, C., Saito, T., Murayama, A., Kuwagata, M., Kageyama, H., Yagi, M., Satoh, K. and Shioda, S. (2011). Seeking gene candidates responsible for developmental origins of health and disease. Congenit. Anom. 51, 110-125.
55. Ohtaki, H., Funahashi, H., Dohi, K., Oguro, T., Horai, R., Asano, M., Iwakura, Y., Yin, L., Matsunaga, M., Goto, N. et al. (2003). Suppression of oxidative neuronal damage after transient middle cerebral artery occlusion in mice lacking interleukin- 1. Neurosci. Res. 45, 313-324.
56. Ohtaki, H., Nakamachi, T., Dohi, K., Aizawa, Y., Takaki, A., Hodoyama, K., Yofu, S., Hashimoto, H., Shintani, N., Baba, A. et al. (2006). Pituitary adenylate cyclaseactivating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6. Proc. Natl. Acad. Sci. USA 103, 7488-7493.
57. Ohtaki, H., Takeda, T., Dohi, K., Yofu, S., Nakamachi, T., Satoh, K., Hiraizumi, Y., Miyaoka, H., Matsunaga, M. and Shioda, S. (2007). Increased mitochondrial DNA oxidative damage after transient middle cerebral artery occlusion in mice. Neurosci. Res. 58, 349-355.
58. Ohtaki, H., Nakamachi, T., Dohi, K. and Shioda, S. (2008a). Role of PACAP in ischemic neural death. J. Mol. Neurosci. 36, 16-25.
59. Ohtaki, H., Ylostalo, J. H., Foraker, J. E., Robinson, A. P., Reger, R. L., Shioda, S. and Prockop, D. J. (2008b). Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc. Natl. Acad. Sci. USA 105, 14638-14643.
60. Pera. J., Zawadzka, M., Kaminska, B. and Szczudlik, A. (2004). Influence of chemical and ischemic preconditioning on cytokine expression after focal brain ischemia. J. Neurosci. Res. 78, 132-140.
61. Popa-Wagner, A., Craitoiu, S. and Buga, A. M. (2009). Central nervous system aging and regeneration after injuries. A systematic approach. Rom. J. Morphol. Embryol. 50, 155-167.
62. Pruissen, D. M., Kappelle, L. J., Rosendaal, F. R. and Algra, A. (2009). Genetic association studies in ischaemic stroke: replication failure and prospects. Cerebrovasc. Dis. 27, 290-294.
63. Qin, H. P., Mei, G. H., Wei, L. and Jiang, J. Y. (2008). Effect of profound hypothermia on genomics of hippocampus following complete cerebral ischemia in rats. Neurol. Res. 30, 536-541.
64. Ramos-Fernandez, M., Bellolio, M. F. and Stead, L. G. (2011). Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review. J. Stroke Cerebrovasc. Dis. 20, 47-54.
65. Romanic, A. M., White, R. F., Arieth, A. J., Ohlstein, E. H. and Barone, F. C. (1998). Matrix metalloproteinases expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infract size. Stroke 29, 1020-1030.
66. Rosenberg, G. A. (2002). Matrix metalloproteinases in neuroinflammation. Glia 39, 279-291.
67. Rosenberg, G. A., Cunningham, L. A., Wallace, J., Alexander, S., Estrada, E. Y., Grossetete, M., Razhagi, A., Miller, K. and Gearing, A. (2001). Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res. 893, 104-112.
68. Rosenzweig, B. A., Pine, P. S., Domon, O. E., Morris, S. M., Chen, J. J. and Sistare, F. D. (2004). Dye bias correction in dual-labeled cDNA microarray gene expression measurements. Environ. Health Perspect. 112, 480-487.
69. Rossi, D. and Zlotnik, A. (2000). The biology of chemokines and their receptors. Annu. Rev. Immunol. 18, 217-242.
70. Rymner, M. M., Akhtar, N., Martin, C. and Summers, D. (2010). Management of acute ischemic stroke: time is brain. Mo. Med. 107, 333-337.
71. Schäfer, B. W. and Heizmann, C. W. (1996). The S100 family of EF-hand calciumbinding proteins: functions and pathology. Trends Biochem. Sci. 21, 134-140.
72. Schäfer, B. W., Fritschy, J. M., Murmann, P., Troxler, H., Durussel, I., Heizmann, C. W. and Cox, J. A. (2000). Brain S100A5 is a novel calcium-, zinc-, and copper ionbinding protein of the EF-hand superfamily. J. Biol. Chem. 275, 30623-30630.
73. Sedaghat, F. and Notopoulos, A. (2008). S100 protein family and its application in clinical practice. Hippokratia 12, 198-204.
74. Semple, B. D., Kossmann, T. and Morganti-Kossmann, M. C. (2010). Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J. Cereb. Blood Flow Metab. 30, 459-473.
75. Shimazu, M., Mizushima, H., Sasaki, K., Arai, Y., Matsumoto, K., Shioda, S. and Nakai, Y. (1994). Expression of c-fos in the rat cerebral cortex after focal ischemia and reperfusion. Brain Res. Bull. 33, 689-697.
76. Shioda, S., Ozawa, H., Dohi, K., Mizushima, H., Matsumoto, K., Nakajo, S., Takaki, A., Zhou, C. J., Nakai, Y. and Arimura, A. (1998). PACAP protects hippocampal neurons against apoptosis: involvement of JNK/SAPK signaling pathway. Ann. NY Acad. Sci. 865, 111-117.
77. Slemmer, J. E., Shacka, J. J., Sweeney, M. I. and Weber, J. T. (2008). Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Curr. Med. Chem. 15, 404-414.
78. Stamova, B., Xu, H., Jickling, G., Bushnell, C., Tian, Y., Ander, B. P., Zhan, X., Liu, D., Turner, R., Adamczyk, P. et al. (2010). Gene expression profiling of blood for the prediction of ischemic stroke. Stroke 41, 2171-2177.
79. Suzuki, T., Higgins, P. J. and Crawford, D. R. (2000). Control selection for RNA quantitation. Biotechniques 29, 332-337.
80. Tang, Y., Pacary, E., Fréret, T., Divoux, D., Petit, E., Schumann-Bard, P. and Bernaudin, M. (2006). Effect of hypoxic preconditioning on brain genomic response before and following ischemia in the adult mouse: identification of potential neuroprotective candidates for stroke. Neurobiol. Dis. 21, 18-28.
81. Tano, K., Hamamoto, H., Ito, T., Sumiya, E., Rakwal, R., Shibato, J., Masuo, Y., Ijiri, K., Sekimizu, K. and Akimitsu, N. (2010a). Reduced expression of Sytl 1 and Ccdc21 and impaired induction of Mt I by oxidative stress in SII-K1 knockout mice. Drug Discov. Ther. 4, 368-372.
82. Tano, K., Mizuno, R., Okada, T., Rakwal, R., Shibato, J., Masuo, Y., Ijiri, K. and Akimitsu, N. (2010b). MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett. 584, 4575-4580.
83. Turner, D. A. and Adamson, D. C. (2011). Neuronal-astrocyte metabolic interactions: understanding the transition into abnormal astrocytoma metabolism. J. Neuropathol. Exp. Neurol. 70, 167-176.
84. Vogel, T. and Gruss, P. (2009). Expression of leukaemia associated transcription factor Af9/Mllt3 in the cerebral cortex of the mouse. Gene Expr. Patterns 9, 83-93.
85. Wang, G., Guo, Q., Hossain, M., Fazio, V., Zeynalov, E., Janigro, D., Mayberg, M. R. and Namura, S. (2009). Bone marrow derived cells are the major source of MMP-9 contributing to blood-brain barrier dysfunction and infarct formation after ischemic stroke in mice. Brain Res. 1294, 183-192.
86. Wechsler, L. R. (2011). Imaging evaluation of acute ischemic stroke. Stroke 42, S12-S15.
87. Xu, L., Emery, J. F., Ouyang, Y. B., Voloboueva, L. A. and Giffard, R. G. (2010). Astrocyte targeted overexpression of Hsp72 or SOD2 reduces neuronal vulnerability to forebrain ischemia. Glia 58, 1042-1049.
88. Yamashita, T., Sawamoto, K., Suzuki, S., Suzuki, N., Adachi, K., Kawase, T., Mihara, M., Ohsugi, Y., Abe, K. and Okano, H. (2005). Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons. J. Neurochem. 94, 459-468.
89. Yao, H., Nakahara, T., Nakagawa, N., Hashimoto, K. and Kuroki, T. (2009). Regional and temporal changes in proteomic profile after middle cerebral artery occlusion with or without reperfusion in rats. Neurochem. Res. 34, 1999-2007.
90. Yenari, M. A. and Hemmen, T. M. (2010). Therapeutic hypothermia for brain ischemia: where have we come and where do we go? Stroke 41, S72-S74.
91. Yong, V. W., Power, C., Forsyth, P. and Edwards, D. R. (2001). Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci. 2, 502-511.
92. Zhan, X., Ander, B. P., Jickling, G., Turner, R., Stamova, B., Xu, H., Liu, D., Davis, R. R. and Sharp, F. R. (2010). Brief focal cerebral ischemia that simulates transient ischemic attacks in humans regulates gene expression in rat peripheral blood. J. Cereb. Blood Flow Metab. 30, 110-118.
93. Zimmer, D. B., Chaplin, J., Baldwin, A. and Rast, M. (2005). S100-mediated signal transduction in the nervous system and neurological diseases. Cell. Mol. Biol. (Noisyle- grand) 51, 201-214.